Literature DB >> 4037750

Decreased sympathetic neuronal uptake in idiopathic orthostatic hypotension.

R J Polinsky, D S Goldstein, R T Brown, H R Keiser, I J Kopin.   

Abstract

The disappearance rates from plasma of intravenously administered levo-norepinephrine (l-NE), dextro-norepinephrine (d-NE), and isoproterenol (ISO) were measured in normal subjects and in patients with either multiple-system atrophy (MSA) or idiopathic orthostatic hypotension (IOH). The two isomers, l-NE and d-NE, were removed at similar rates in all groups. In normal subjects, the d and l isomers of norepinephrine were cleared more rapidly than ISO. In patients with IOH, the initial rates of disappearance of the NE isomers from plasma were slower than normal and similar to the rate for ISO disappearance. Plasma NE levels, NE clearance, and the apparent release rate of NE into plasma from sympathetic neurons were significantly lower in patients with IOH than in normal subjects. Only the apparent NE secretion rate was related to the baseline plasma NE level. Sympathetic neuronal dysfunction in IOH is attended by a reduction in the clearance of NE. The very low plasma NE levels, in association with the striking reduction in NE clearance, suggest that in IOH there is a marked decrease in NE release. NE clearance and apparent NE secretion rate are normal in MSA, consistent with a central nervous system dysfunction in regulating the sympathetic nervous system. Neuronal uptake of NE in humans does not appear to be stereoselective.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4037750     DOI: 10.1002/ana.410180109

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Proceedings of the 8th meeting of the Clinical Autonomic Research Society. London, November 16, 1990. Abstracts.

Authors: 
Journal:  Clin Auton Res       Date:  1991-03       Impact factor: 4.435

Review 2.  Other autonomic neuropathies associated with ganglionic antibody.

Authors:  Paola Sandroni; Phillip A Low
Journal:  Auton Neurosci       Date:  2008-12-04       Impact factor: 3.145

3.  Differences in overshoot of blood pressure after head-up tilt in two groups with chronic autonomic failure: pure autonomic failure and multiple system atrophy.

Authors:  Masato Asahina; Tim M Young; Katharine Bleasdale-Barr; Christopher J Mathias
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

4.  Computational modeling reveals multiple abnormalities of myocardial noradrenergic function in Lewy body diseases.

Authors:  David S Goldstein; Mark J Pekker; Graeme Eisenhofer; Yehonatan Sharabi
Journal:  JCI Insight       Date:  2019-07-23

5.  Central and peripheral effects of arecoline in patients with autonomic failure.

Authors:  R J Polinsky; R T Brown; M T Curras; S M Baser; C E Baucom; D R Hooper; A M Marini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

6.  Gastrin responses in patients with adrenergic insufficiency.

Authors:  R J Polinsky; I L Taylor; V Weise; I J Kopin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

Review 7.  Neurogenic orthostatic hypotension: a pathophysiological approach.

Authors:  David S Goldstein; Yehonatan Sharabi
Journal:  Circulation       Date:  2009-01-06       Impact factor: 29.690

8.  Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure.

Authors:  I T Meredith; M D Esler; H S Cox; G W Lambert; G L Jennings; G Eisenhofer
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

9.  Computed tomography, magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in multiple system atrophy and pure autonomic failure.

Authors:  M J Fulham; R M Dubinsky; R J Polinsky; R A Brooks; R T Brown; M T Curras; S Baser; M Hallett; G Di Chiro
Journal:  Clin Auton Res       Date:  1991-03       Impact factor: 4.435

10.  Orthostatic hypotension as an early finding in Parkinson's disease.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.